The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 02, 2021
Filed:
Dec. 21, 2018
Applicant:
Shepherd Therapeutics, Inc., Natick, MA (US);
Inventors:
Katherine Arline, Cambridge, MA (US);
Jamie Dempsey Barber, Hanover, MA (US);
William M. Siders, Franklin, MA (US);
Johanne Kaplan, Sherborn, MA (US);
Assignee:
Shepherd Therapeutics, Inc., Natick, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4709 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); A61K 47/61 (2017.01); A61K 31/282 (2006.01); A61K 31/4745 (2006.01); A61K 31/44 (2006.01); A61K 31/704 (2006.01); A61K 31/7048 (2006.01); A61K 33/242 (2019.01); A61K 31/475 (2006.01); A61K 31/337 (2006.01); A61K 31/513 (2006.01); A61K 31/675 (2006.01); A61K 31/555 (2006.01); A61K 31/506 (2006.01); A61K 31/655 (2006.01); A61K 31/7068 (2006.01); A61K 47/69 (2017.01); A61K 31/495 (2006.01); A61K 31/517 (2006.01); A61K 47/68 (2017.01); A61K 9/127 (2006.01); A61K 47/36 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4709 (2013.01); A61K 9/127 (2013.01); A61K 31/282 (2013.01); A61K 31/337 (2013.01); A61K 31/44 (2013.01); A61K 31/475 (2013.01); A61K 31/4745 (2013.01); A61K 31/495 (2013.01); A61K 31/506 (2013.01); A61K 31/513 (2013.01); A61K 31/517 (2013.01); A61K 31/555 (2013.01); A61K 31/655 (2013.01); A61K 31/675 (2013.01); A61K 31/704 (2013.01); A61K 31/7048 (2013.01); A61K 31/7068 (2013.01); A61K 33/242 (2019.01); A61K 45/06 (2013.01); A61K 47/36 (2013.01); A61K 47/61 (2017.08); A61K 47/6801 (2017.08); A61K 47/6937 (2017.08); A61P 35/00 (2018.01); A61P 35/04 (2018.01);
Abstract
The disclosure relates to a method of treating cancer by administering to the subject a therapeutically effective amount of a composition comprising pyrvinium pamoate, optionally in combination with at least one additional therapeutic agent or modality.